ANG Lifesciences India Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

131.37

207.01

348.67

154.38

126.83

Operating profit

9.12

11.07

65.08

13.87

12.08

Interest

9.33

10.32

7.85

2.97

2.87

Gross profit

0.62

10.59

58.18

11.46

9.63

EPS (Rs)

-6.62

-0.51

38.31

13.56

11.76

Other income

0.84

9.84

0.95

0.56

0.42

Stock adjustment

-6.74

-4.22

-4.47

-4.30

-0.59

Raw material

93.93

151.12

234.49

108.26

89.56

Power and fuel

-

-

-

-

-

Employee expenses

15.90

20.27

18.32

13.68

7.94

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

19.15

28.76

35.25

22.88

17.84

Provisions made

-

-

-

-

-

Depreciation

7.75

8.52

5.12

1.32

1.23

Taxation

-0.22

2.73

13.35

3.11

2.31

Net profit / loss

-8.65

-0.66

39.71

7.03

6.10

Extra ordinary item

-1.74

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.06

13.06

10.37

5.18

5.18

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

6.94

5.35

18.67

8.98

9.53

GPM (%)

.47

4.88

16.64

7.39

7.57

NPM (%)

-6.54

-0.31

11.36

4.54

4.79